Elevated glucose is associated with hemorrhagic transformation after mechanical thrombectomy in acute ischemic stroke patients with severe pretreatment hypoperfusion.
Aged
Aged, 80 and over
Brain
/ metabolism
Brain Ischemia
/ therapy
Cerebral Blood Volume
/ physiology
Cerebral Hemorrhage
/ etiology
Cerebrovascular Circulation
/ physiology
Female
Glucose
/ metabolism
Hemorrhage
Humans
Intracranial Hemorrhages
/ etiology
Ischemia
/ therapy
Magnetic Resonance Imaging
/ methods
Male
Middle Aged
Perfusion
/ adverse effects
Perfusion Imaging
/ methods
Reperfusion
Stroke
/ therapy
Thrombectomy
/ adverse effects
Tomography, X-Ray Computed
/ methods
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 06 2020
29 06 2020
Historique:
received:
15
11
2019
accepted:
04
05
2020
entrez:
1
7
2020
pubmed:
1
7
2020
medline:
16
1
2021
Statut:
epublish
Résumé
Several pretreatment variables such as elevated glucose and hypoperfusion severity are related to brain hemorrhage after endovascular treatment of acute stroke. We evaluated whether elevated glucose and severe hypoperfusion have synergistic effects in the promotion of parenchymal hemorrhage (PH) after mechanical thrombectomy (MT). We included 258 patients MT-treated who had a pretreatment computed tomography perfusion (CTP) and a post-treatment follow-up MRI. Severe hypoperfusion was defined as regions with cerebral blood volume (CBV) values < 2.5% of normal brain [very-low CBV (VLCBV)-regions]. Median baseline glucose levels were 119 (IQR = 105-141) mg/dL. Thirty-nine (15%) patients had pretreatment VLCBV-regions, and 42 (16%) developed a PH after MT. In adjusted models, pretreatment glucose levels interacted significantly with VLCBV on the prediction of PH (p-interaction = 0.011). In patients with VLCBV-regions, higher glucose was significantly associated with PH (adjusted-OR = 3.15; 95% CI = 1.08-9.19, p = 0.036), whereas this association was not significant in patients without VLCBV-regions. CBV values measured at pretreatment CTP in coregistered regions that developed PH or infarct at follow-up were not correlated with pretreatment glucose levels, thus suggesting the existence of alternative deleterious mechanisms other than direct glucose-driven hemodynamic impairments. Overall, these results suggest that both severe hypoperfusion and glucose levels should be considered in the evaluation of adjunctive neuroprotective strategies.
Identifiants
pubmed: 32601437
doi: 10.1038/s41598-020-67448-x
pii: 10.1038/s41598-020-67448-x
pmc: PMC7324383
doi:
Substances chimiques
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10588Références
Saver, J. L. et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: A meta-analysis. JAMA 316, 1279 (2016).
doi: 10.1001/jama.2016.13647
Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet 387, 1723–1731 (2016).
doi: 10.1016/S0140-6736(16)00163-X
Renú, A. et al. Relevance of blood–brain barrier disruption after endovascular treatment of ischemic stroke. Stroke 46, 673–679 (2015).
doi: 10.1161/STROKEAHA.114.008147
Khatri, P., Wechsler, L. R. & Broderick, J. P. Intracranial hemorrhage associated with revascularization therapies. Stroke 38, 431–440 (2007).
doi: 10.1161/01.STR.0000254524.23708.c9
Lee, Y. B. et al. Predictors and impact of hemorrhagic transformations after endovascular thrombectomy in patients with acute large vessel occlusions. J. Neurointerv. Surg. 11, 469–473 (2019).
doi: 10.1136/neurintsurg-2018-014080
Hao, Y. et al. Predictors for symptomatic intracranial hemorrhage after endovascular treatment of acute ischemic stroke. Stroke 48, 1203–1209 (2017).
doi: 10.1161/STROKEAHA.116.016368
Raychev, R. et al. The impact of general anesthesia, baseline ASPECTS, time to treatment, and IV tPA on intracranial hemorrhage after neurothrombectomy: Pooled analysis of the SWIFT PRIME, SWIFT, and STAR trials. J. Neurointerv. Surg. 12, 2–6 (2020).
doi: 10.1136/neurintsurg-2019-014898
van Kranendonk, K. R. et al. Clinical and imaging markers associated with hemorrhagic transformation in patients with acute ischemic stroke. Stroke 50, 2037–2043 (2019).
doi: 10.1161/STROKEAHA.118.024255
Rai, A. T., Raghuram, K., Carpenter, J. S., Domico, J. & Hobbs, G. Pre-intervention cerebral blood volume predicts outcomes in patients undergoing endovascular therapy for acute ischemic stroke. J. Neurointerv. Surg. 5, i25–i32. https://doi.org/10.1136/neurintsurg-2012-010293 (2013).
doi: 10.1136/neurintsurg-2012-010293
pubmed: 22434904
Bhatt, A. et al. Lower pretreatment cerebral blood volume affects hemorrhagic risks after intra-arterial revascularization in acute stroke. Neurosurgery 63, 874–879 (2008).
doi: 10.1227/01.NEU.0000333259.11739.AD
Renú, A. et al. Brain hemorrhage after endovascular reperfusion therapy of ischemic stroke: a threshold-finding whole-brain perfusion CT study. J. Cereb. Blood Flow Metab. 37, 153–165 (2017).
doi: 10.1177/0271678X15621704
Natarajan, S. K. et al. Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. J. Neurosurg. 114, 1785–1799 (2011).
doi: 10.3171/2011.1.JNS10884
Chamorro, Á et al. Glucose modifies the effect of endovascular thrombectomy in patients with acute stroke. Stroke 50, 690–696 (2019).
doi: 10.1161/STROKEAHA.118.023769
Hafez, S., Coucha, M., Bruno, A., Fagan, S. C. & Ergul, A. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy. Transl. Stroke Res. 5, 442–453 (2014).
doi: 10.1007/s12975-014-0336-z
Desilles, J.-P. et al. Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation. Stroke 48, 1932–1940 (2017).
doi: 10.1161/STROKEAHA.117.017080
Kawai, N., Keep, R. F. & Betz, A. L. Hyperglycemia and the vascular effects of cerebral ischemia. Stroke 28, 149–154 (1997).
doi: 10.1161/01.STR.28.1.149
Nakai, H., Yamamoto, Y. L., Diksic, M., Worsley, K. J. & Takara, E. Triple-tracer autoradiography demonstrates effects of hyperglycemia on cerebral blood flow, pH, and glucose utilization in cerebral ischemia of rats. Stroke 19, 764–772 (1988).
doi: 10.1161/01.STR.19.6.764
Quast, M. J. et al. Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats. J. Cereb. Blood Flow Metab. 17, 553–559 (1997).
doi: 10.1097/00004647-199705000-00009
Duckrow, R. B., Beard, D. C. & Brennan, R. W. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 18, 52–58 (1987).
doi: 10.1161/01.STR.18.1.52
Ginsberg, M. D., Welsh, F. A. & Budd, W. W. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat. I. Local cerebral blood flow and glucose utilization. Stroke 11, 347–354 (1980).
doi: 10.1161/01.STR.11.4.347
Venables, G. S., Miller, S. A., Gibson, G., Hardy, J. A. & Strong, A. J. The effects of hyperglycaemia on changes during reperfusion following focal cerebral ischaemia in the cat. J. Neurol. Neurosurg. Psychiatry 48, 663–669 (1985).
doi: 10.1136/jnnp.48.7.663
Wagner, K. R., Kleinholz, M., de Courten-Myers, G. M. & Myers, R. E. Hyperglycemic versus normoglycemic stroke: Topography of brain metabolites, intracellular pH, and infarct size. J. Cereb. Blood Flow Metab. 12, 213–222 (1992).
doi: 10.1038/jcbfm.1992.31
Gisselsson, L., Smith, M.-L. & Siesjö, B. K. Hyperglycemia and focal brain ischemia. J. Cereb. Blood Flow Metab. 19, 288–297 (1999).
doi: 10.1097/00004647-199903000-00007
Tan, I. Y. L. et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR. Am. J. Neuroradiol. 30, 525–531 (2009).
doi: 10.3174/ajnr.A1408
Hacke, W. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352, 1245–1251 (1998).
doi: 10.1016/S0140-6736(98)08020-9
Campbell, B. C. V. et al. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 41, 82–88 (2010).
doi: 10.1161/STROKEAHA.109.562116
Campbell, B. C. V. et al. Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann. Neurol. 73, 510–519 (2013).
doi: 10.1002/ana.23837
Hermitte, L. et al. Very low cerebral blood volume predicts parenchymal hematoma in acute ischemic stroke. Stroke 44, 2318–2320 (2013).
doi: 10.1161/STROKEAHA.113.001751
Yassi, N. et al. Prediction of poststroke hemorrhagic transformation using computed tomography perfusion. Stroke 44, 3039–3043 (2013).
doi: 10.1161/STROKEAHA.113.002396
Gray, C. S. et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet. Neurol. 6, 397–406 (2007).
doi: 10.1016/S1474-4422(07)70080-7
McCormick, M. et al. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann. Neurol. 67, 570–578 (2010).
pubmed: 20437554
Johnston, K. C. et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: The SHINE randomized clinical trial. JAMA 322, 326–335 (2019).
doi: 10.1001/jama.2019.9346
Amaro, S. et al. Uric acid improves glucose-driven oxidative stress in human ischemic stroke. Ann. Neurol. 77, 775–783 (2015).
doi: 10.1002/ana.24378
Martini, S. R. & Kent, T. A. Hyperglycemia in acute ischemic stroke: A vascular perspective. J. Cereb. Blood Flow Metab. 27, 435–451 (2007).
doi: 10.1038/sj.jcbfm.9600355
Suh, S. W. et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann. Neurol. 64, 654–663 (2008).
doi: 10.1002/ana.21511
Kamada, H., Yu, F., Nito, C. & Chan, P. H. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: Relation to blood–brain barrier dysfunction. Stroke 38, 1044–1049 (2007).
doi: 10.1161/01.STR.0000258041.75739.cb
Bevers, M. B., Vaishnav, N. H., Pham, L., Battey, T. W. & Kimberly, W. T. Hyperglycemia is associated with more severe cytotoxic injury after stroke. J. Cereb. Blood Flow Metab. 37, 2577–2583 (2017).
doi: 10.1177/0271678X16671730
Neuberger, U. et al. Classification of bleeding events. Stroke 48, 1983–1985 (2017).
doi: 10.1161/STROKEAHA.117.016735